26.1 C
New Delhi

Molnupiravir and Paxlovid , the heavily promoted antiviral drug ,Are they really safe ?

Date:

Share post:

So many new drugs come to the market and marketed as the panacea for the illness.
History reveals many such drugs had to be withdrawn due to toxicity.

If you have practiced medicine in the last 2 to 3 decades will remember many drugs that were withdrawn due to severe adverse effects.

Cisapride was used for heartburn,flatulence got withdrawn in 2003,it was shown to cause heart rhythm disturbances

Rofecoxib was a drug prescribed right and left for arthritic pain but later shown causing more heart attacks and thus withdrawn from the market.

This drug was marketed by Merck the same company promoting Molnupiravir the anti COVID pill which has been flagged up with problems specially to pregnant women and those planning to get pregnant

Terfenadine was used for allergy drug.It was withdrawn

Rosiglitazone an anti diabetic drug had 13,000 law suits as it was shown to cause more heart attacks.

When the modern Allopathy looks at Ayurveda as herbal medicine field,the reality is long list of medicines that were used heavily in allopathy but got withdrawn due to toxicities.

Why this post now?

Molnupiravir and Paxlovid two antiviral drugs promoted heavily for the COVID but we have to be cautious that no drug is safer and doctors should exercise caution in not going overboard to prescribe to everybody( an Indian phenomenon).

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

The Precipice of Global Conflict: Analyzing a US-Israel Strike on Iran, Tehran’s Retaliation, and the Systematic Shift of World Order

For decades, the “shadow war” between Israel and Iran, with the United States acting as Israel’s primary security...

India: The Emerging Global Powerhouse of Artificial Intelligence

In the global race for technological supremacy, India is no longer just a participant; it is rapidly becoming...

Transforming the Heartland: Yogi Adityanath’s East Asian Outreach and the Road to a $1 Trillion Economy

In a bold move to reposition Uttar Pradesh (UP) as a global investment destination, Chief Minister Yogi Adityanath...

A Paradigm Shift: PM Narendra Modi’s Landmark Israel Visit and the Redefining of Global Geopolitics

In July 2017, Narendra Modi became the first Indian Prime Minister to set foot on Israeli soil. While...